FDA Inspection
HCG Manavata Cancer CentreHCG Manavata Cancer Centre – FDA Inspection, Sep 27, 2023
Record Details
This FDA Inspection record concerns HCG Manavata Cancer Centre, with an inspection on September 27, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f8215b21-25f6-415d-bc0d-07953504d70f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1221683
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of HCG Manavata Cancer Centre
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 6, 2022 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 27, 2019 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for HCG Manavata Cancer Centre
- FDA Inspection 1179266 - 2022-08-06
- FDA Inspection 1102925 - 2019-09-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.